ClinicalTrials.Veeva

Menu

ADMA and Mechanical Ventilation in Preterm Infants

A

Amsterdam UMC, location VUmc

Status

Completed

Conditions

Premature Birth

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to study the relation between mechanical ventilation and ADMA concentrations at birth.

Full description

Nitric oxide (NO) plays an important role in the normal development and maturation of the lungs. In addition, NO is an important mediator of vascular smooth muscle relaxation, ventilation perfusion matching, neurotransmission and host defence and bacteriostasis. Asymmetric dimethylarginine (ADMA) is an endogenous derivative of arginine that inhibits NOS and thereby the bioavailability of NO. Preterm infants have increased concentrations of ADMA. Therefore, inhibition of NO by increased concentrations of ADMA which could be associated with reduced pulmonary functioning.

Sex

All

Ages

Under 32 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age < 32 weeks
  • Birth weight < 1500 gram
  • Written informed consent of parents

Exclusion criteria

  • Congenital abnormalities
  • Chromosomal abnormalities

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems